Trial IM011-1130 for Plaque Psoriasis

Study ID: IM011-1130 for Plaque Psoriasis

Summary

Study Details

Study Name	Age Requirements	Length of Study	Type of Treatment
IM011-1130	40 years or older	Up to 5 Years (13 visits to the clinic)	Oral or Injection

Adult’s Psoriasis Study (5 Years)

Who Can Participate?

Adults aged 40 or above with moderate to severe plaque psoriasis may participate.

Inclusion Criteria

Psoriasis on 10% or greater body surface area
One or more of the following should apply
Current cigarette smoker (vaping does not qualify)
Diagnosis of hypertension or dyslipidemia
Use of blood pressure-lowering medications or lipid-lowering medications
Type 1 or type 2 diabetes
Have had heart surgery, cardiac arrest, or stroke
Obesity (body mass index ≥ 30 kg/m2)
Family history of heart attacks in a relative younger than 55 or a female immediate family member younger than 65

Participant Information

Participate and receive study treatment at no cost
Regular visits with study doctors who specialise in treating psoriasis (up to 13 visits)
Will receive either an investigative oral or subcutaneous treatment (study drug)
Reimbursement for study-related expenses may be provided

How Long Will The Study Last?

Approximately 5 years

Contact us about joining the trial

To be eligible for this trial, applicants MUST have a skin condition. We DO NOT accept volunteers who do not have a skin disease.

Fill out this form to get in touch or call our clinical trial line at #(289)-763-8666. We will contact you in 1-2 business days regarding your application to participate in the trial.

First Name

Last Name

Phone Number

Email Address

Postal Code

Sex

Best Time to Reach You

Best Contact Method

Check this box to confirm you meet the study requirements, and consent to: recieving text notifications/emails about the trial, and (1) sharing your information with the study site, and (2) our Privacy Policy (see below). All provided information is confidential and will not be shared without your consent.

Privacy Policy for SimcoDerm Clinical Trials

Your privacy is important to us, and we take the protection of your personal health information (PHI) seriously. This policy explains how we collect, use, and protect your information.

We collect information directly from you, including your name, contact details, health information, and treatment history.

We use your information to determine eligibility for clinical trials, manage appointments, and communicate with you about your participation in clinical trials.

Data Protection:

Your information is stored securely and is only accessible by authorized personnel. We use data encryption, conduct security audits, and implement strict access controls to ensure the protection of your personal information.

You have the right to access, amend, or request the deletion of your health records. To exercise these rights, send a request to our clinical trial support team.